Global Darier Disease Drugs Market by Treatment Type (Medication, Surgery), Drugs (Oral Retinoids, Topical Retinoids), Distribution Channel, End- User - Forecast 2024-2030- Product Image

Sale

Global Darier Disease Drugs Market by Treatment Type (Medication, Surgery), Drugs (Oral Retinoids, Topical Retinoids), Distribution Channel, End- User - Forecast 2024-2030

Report
198 Pages
March 2024
Region: Global
360iResearch™
ID: 5674889

UP TO €850EUR$875USD£726GBP OFF until Dec 31^st 2024

The Darier Disease Drugs Market size was estimated at USD 77.12 billion in 2023, USD 81.58 billion in 2024, and is expected to grow at a CAGR of 6.18% to reach USD 117.36 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Darier Disease Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Darier Disease Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Darier Disease Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergan plc, Bausch Health Companies Inc., BridgeBio Inc, Galderma Laboratories, L.P, GlaxoSmithKline plc, Glenmark Pharmaceuticals Inc, Mayne Pharma Group Limited, Merck KGaA, Nimble Pharmaceuticals, Novartis AG, Recursion Pharmaceuticals, Inc., Sigmapharm Laboratories, LLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, and TOLMAR Inc.

Market Segmentation & Coverage

This research report categorizes the Darier Disease Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment Type
- Medication
- Surgery
Drugs
- Oral Retinoids
- Topical Retinoids
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
End- User
- Dermatologist
- Homecare
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Darier Disease Drugs Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Darier Disease Drugs Market?
What are the technology trends and regulatory frameworks in the Darier Disease Drugs Market?
What is the market share of the leading vendors in the Darier Disease Drugs Market?
Which modes and strategic moves are suitable for entering the Darier Disease Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Darier Disease Drugs Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High risk of Darier diseases in economies
5.1.1.2. Rising investments in R&D to develop novel drugs
5.1.1.3. Increasing awareness among consumers
5.1.2. Restraints
5.1.2.1. Limited reimbursement for Darier disease drugs
5.1.3. Opportunities
5.1.3.1. Emergence of novel dermatological preparations for Darier disorders
5.1.3.2. Improvements in the supply chain to enhance the availability of drugs
5.1.4. Challenges
5.1.4.1. Complexity and prolonged nature of treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Darier Disease Drugs Market, by Treatment Type

6.1. Introduction
6.2. Medication
6.3. Surgery

7. Darier Disease Drugs Market, by Drugs

7.1. Introduction
7.2. Oral Retinoids
7.3. Topical Retinoids

8. Darier Disease Drugs Market, by Distribution Channel

8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy

9. Darier Disease Drugs Market, by End- User

9.1. Introduction
9.2. Dermatologist
9.3. Homecare
9.4. Hospitals
9.5. Specialty Clinics

10. Americas Darier Disease Drugs Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Darier Disease Drugs Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Darier Disease Drugs Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Allergan plc
14.1.2. Bausch Health Companies Inc.
14.1.3. BridgeBio Inc
14.1.4. Galderma Laboratories, L.P
14.1.5. GlaxoSmithKline plc
14.1.6. Glenmark Pharmaceuticals Inc
14.1.7. Mayne Pharma Group Limited
14.1.8. Merck KGaA
14.1.9. Nimble Pharmaceuticals
14.1.10. Novartis AG
14.1.11. Recursion Pharmaceuticals, Inc.
14.1.12. Sigmapharm Laboratories, LLC
14.1.13. Sun Pharmaceutical Industries Ltd.
14.1.14. Teva Pharmaceutical Industries Ltd
14.1.15. TOLMAR Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. DARIER DISEASE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. DARIER DISEASE DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. DARIER DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DARIER DISEASE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DARIER DISEASE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DARIER DISEASE DRUGS MARKET DYNAMICS
FIGURE 7. DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2023 VS 2030 (%)
FIGURE 10. DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2023 VS 2030 (%)
FIGURE 14. DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DARIER DISEASE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DARIER DISEASE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DARIER DISEASE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. DARIER DISEASE DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. DARIER DISEASE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. DARIER DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DARIER DISEASE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. DARIER DISEASE DRUGS MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DARIER DISEASE DRUGS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 9. DARIER DISEASE DRUGS MARKET SIZE, BY ORAL RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DARIER DISEASE DRUGS MARKET SIZE, BY TOPICAL RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 12. DARIER DISEASE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DARIER DISEASE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. DARIER DISEASE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 16. DARIER DISEASE DRUGS MARKET SIZE, BY DERMATOLOGIST, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. DARIER DISEASE DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. DARIER DISEASE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. DARIER DISEASE DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 35. CANADA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. CANADA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 39. MEXICO DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. MEXICO DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DARIER DISEASE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 57. CHINA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CHINA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 61. INDIA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. INDIA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. JAPAN DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. JAPAN DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 93. THAILAND DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. THAILAND DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 106. DENMARK DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. DENMARK DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. EGYPT DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EGYPT DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 114. FINLAND DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. FINLAND DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. FRANCE DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. GERMANY DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 130. ITALY DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. ITALY DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 142. NORWAY DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. NORWAY DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 146. POLAND DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. POLAND DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 150. QATAR DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. QATAR DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SPAIN DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. TURKEY DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM DARIER DISEASE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM DARIER DISEASE DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM DARIER DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DARIER DISEASE DRUGS MARKET SIZE, BY END- USER, 2018-2030 (USD MILLION)
TABLE 188. DARIER DISEASE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. DARIER DISEASE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. DARIER DISEASE DRUGS MARKET LICENSE & PRICING

Companies Mentioned

Allergan plc
Bausch Health Companies Inc.
BridgeBio Inc
Galderma Laboratories, L.P
GlaxoSmithKline plc
Glenmark Pharmaceuticals Inc
Mayne Pharma Group Limited
Merck KGaA
Nimble Pharmaceuticals
Novartis AG
Recursion Pharmaceuticals, Inc.
Sigmapharm Laboratories, LLC
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd
TOLMAR Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 81.58 Billion
Forecasted Market Value ( USD ) by 2030	$ 117.36 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,800GBP €3641EUR$3,749USD£3,111GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,546GBP €4612EUR$4,749USD£3,941GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,293GBP €5584EUR$5,749USD£4,770GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5899EUR$6,074USD£5,040GBP €6555EUR$6,749USD£5,600GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,534GBP €8497EUR$8,749USD£7,260GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Pharmaceutical Drugs Global Market Report 2024

Asia-Pacific Pharmaceutical Industry Outlook 2023

Drafting Effective Pharmaceutical Patents Training Course (May 13-16, 2024)

Darier Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Global Uveitis Drugs Market by Treatment Type (Analgesics, Antibiotics, Antifungal), Disease Type (Anterior Uveitis, Intermediate Uveitis, Panuveitis), Cause, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030